Publication | Open Access
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
67
Citations
46
References
2017
Year
Vorinostat demonstrated efficacy in patients with ACC supporting the inclusion of HDACi in future studies to treat ACC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1